Griffiths Richard Ian → Silence Therapeutics Plc SLNCF

Stake: 21.70% Shares: 30,844,458 CUSIP: G8128Y157 Class: Ordinary Shares, nominal value of PS0.05 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-06-15

DTC 1.00

39 shares short · 0.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $694K

Point72 Asset Mgmt

Post-Filing Returns · since 2026-07-06 on SLNCF

+1 day

0.0%

+5 days

0.0%

+30 days

—

+60 days

—

+90 days

—

+180 days

—

Anchor price 1.50 on closest trading day on/after 2026-07-06. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Silence Therapeutics Plc

Filed	Form	Filer	Stake	Shares
2026-08-13	SCHEDULE 13D/A	Griffiths Richard Ian	—	14,391,498	view →
2023-08-14	SC	Griffiths Richard Ian	—	—	view →
2022-07-20	SC	Griffiths Richard Ian	—	—	view →

Other Filings by Griffiths Richard Ian

Filed	Form	Issuer	Stake	Shares
2026-08-13	SCHEDULE 13D/A	Silence Therapeutics Plc	—	14,391,498	view →
2023-08-14	SC	Silence Therapeutics plc SLNCF	—	—	view →
2022-07-20	SC	Silence Therapeutics plc SLNCF	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →